About
Genabio Diagnostics Inc. is a global leader in at-home self-testing and point-of-care diagnostic solutions, focusing on infectious diseases, drug abuse screening, and metabolic health monitoring. The company provides a low-cost, easy-to-use diagnostic platform that combines molecular and serological testing with real-time data analysis, enabling rapid and reliable disease detection and management. Founded to transform diagnostic testing, Genabio offers comprehensive solutions that streamline the entire testing process, from sample collection to data analysis. Their product range includes tests for respiratory infections, sexually transmitted diseases, and COVID-19, as well as drug abuse screening and women’s health self-tests. The company emphasizes affordability and accessibility, making diagnostics efficient for individuals and healthcare providers alike. Headquartered in Bedford, Massachusetts, Genabio Diagnostics has a strong international presence, with products available in major retailers and pharmacies across multiple countries. They serve a diverse customer base, including government agencies, hospitals, and diagnostic laboratories, and are committed to developing advanced diagnostic products through dedicated research and collaboration with clinical sites.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2019
Location
19 Crosby Dr, Bedford, Massachusetts, United States, 01730-1412
